Description
Currently, the clinical management of dengue patients includes blood sample collection and monitoring of Hb concentration. This clearly is intrusive, takes up valuable staff time for collecting blood samples, and could cause a significant delay in data preparation, depending on how close the testing lab is. In addition, the repeated collection of blood will result in additional harm to the tissue beneath the skin, impacting the ability of capillaries to allow substances to pass through and leading to dilutional anemia. This method carries a potential danger for DHF patients experiencing bleeding. Early detection helps in lowering the severity and ultimately, the mortality rate of dengue infections as there is no established cure for the disease. BIA is a method that has demonstrated safety, is typically well-received by patients, and is straightforward to utilize. Therefore, this innovative method of the BIA technique offers a quick, noninvasive, cost-effective solution, making it perfect for use at the bedside and a promising approach for classifying and assessing the risk of patients with DHF. This method will assist healthcare professionals in overseeing and controlling dengue patients.
